151 related articles for article (PubMed ID: 1094950)
1. Comparative effects of amoxycillin and ampicillin in the treatment of experimental mouse infections.
Comber KR; Osborne CD; Sutherland R
Antimicrob Agents Chemother; 1975 Feb; 7(2):179-85. PubMed ID: 1094950
[TBL] [Abstract][Full Text] [Related]
2. Comparative activity of amoxycillin and ampicillin in an experimental bacterial infection in mice.
Hunter PA; Rolinson GN; Witting DA
Antimicrob Agents Chemother; 1973 Sep; 4(3):285-93. PubMed ID: 4586142
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of amoxycillin and ampicillin on the morphology of Escherichia coli in vivo and correlation with activity.
Comber KR; Boon RJ; Sutherland R
Antimicrob Agents Chemother; 1977 Dec; 12(6):736-44. PubMed ID: 337891
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vivo activity of bacampicillin and amoxycillin.
Ekström B; Jalar LP; Magni L
Infection; 1979; 7 Suppl 5():S438-42. PubMed ID: 389821
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of amino penicillins in experimental infections in mice.
Forsgren U; Ekström B; Jalar LP; Magni L
Scand J Infect Dis Suppl; 1978; (14):207-13. PubMed ID: 279973
[TBL] [Abstract][Full Text] [Related]
6. Comparative activities of ampicillin, epicillin and amoxycillin in vitro and in vivo.
Basker MJ; Gwynn MN; White AR
Chemotherapy; 1979; 25(3):170-80. PubMed ID: 256524
[TBL] [Abstract][Full Text] [Related]
7. A clinical comparison of ampicillin, ampicillin esters (bacampicillin and pivampicillin) and amoxycillin in acute exacerbations of chronic bronchitis.
Maesen F; Davies B
Infection; 1979; 7 Suppl 5():S483-6. PubMed ID: 315931
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of amoxycillin/clavulanic acid in experimental Bacteroides fragilis/Escherichia coli mixed infections.
Beale AS; Gisby J; Sutherland R
J Antimicrob Chemother; 1988 Apr; 21(4):451-9. PubMed ID: 3288604
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity and synergy, in vitro and in vivo, of a combination of amoxycillin and flucloxacillin.
Comber KR; Merrikin DJ; Sutherland R
Chemotherapy; 1979; 25(1):30-9. PubMed ID: 253636
[TBL] [Abstract][Full Text] [Related]
10. Serum and sputum antibiotic levels after ampicillin, amoxycillin and bacampicillin chronic bronchitis patients.
Davies B; Maesen F
Infection; 1979; 7 Suppl 5():S465-8. PubMed ID: 315930
[TBL] [Abstract][Full Text] [Related]
11. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
Pankuch GA; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200
[TBL] [Abstract][Full Text] [Related]
12. In vivo activity of amoxicillin.
Rolinson GN
Adv Clin Pharmacol; 1974; 7():40-7. PubMed ID: 4619750
[No Abstract] [Full Text] [Related]
13. Amoxycillin: A review of its antibacterial and pharmacokinietic properties and therapeutic use.
Brogeden RN; Speight TM; Avery GS
Drugs; 1975; 9(2):88-140. PubMed ID: 1126306
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal action of beta-lactam antibiotics on Escherichia coli with particular reference to ampicillin and amoxycillin.
Rolinson GN; Macdonald AC; Wilson DA
J Antimicrob Chemother; 1977 Nov; 3(6):541-53. PubMed ID: 340439
[No Abstract] [Full Text] [Related]
15. Studies on aminopenicillin developments. Proceedings of a symposium. Concluding remarks.
Bergan T
Infection; 1979; 7 Suppl 5():S507-512. PubMed ID: 389828
[TBL] [Abstract][Full Text] [Related]
16. The aminopenicillins: development and comparative properties.
Reeves DS; Bullock DW
Infection; 1979; 7 Suppl 5():S425-33. PubMed ID: 389819
[TBL] [Abstract][Full Text] [Related]
17. Treatment of human leptospira infections with semicillin (ampicillin) or with amoxil (amoxycillin).
Münnich D; Lakatos M
Chemotherapy; 1976; 22(6):372-80. PubMed ID: 954482
[TBL] [Abstract][Full Text] [Related]
18. The relative potency of amoxycillin and ampicillin in vitro and in vivo.
Mattie H; van der Voet GB
Scand J Infect Dis; 1981; 13(4):291-6. PubMed ID: 7031862
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of amoxycillin-clavulanate in an experimental model of murine pneumonia caused by AmpC-non-hyperproducing clinical isolates of Escherichia coli resistant to cefoxitin.
Docobo-Pérez F; Fernández-Cuenca F; Pachón-Ibáñez ME; Pascual A; Pichardo C; Martínez-Martínez L; Pachón J
Clin Microbiol Infect; 2008 Jun; 14(6):582-7. PubMed ID: 18294246
[TBL] [Abstract][Full Text] [Related]
20. Bacterial kill rates of amoxycillin and ampicillin at exponentially diminishing concentrations simulating in vivo conditions.
Bergan T; Carlsen IB
Infection; 1980; Suppl 1():103-8. PubMed ID: 6995345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
